Glenmark, Canada’s SaNOtize to commercialise nasal spray for Covid-19 treatment

Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research and Development Corp on Monday announced an exclusive long term strategic partnership to manufacture, market and distribute nitric oxide nasal spray (NONS) for Covid-19 treatment in India and other Asian markets. The other Asian market include Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor-Leste and Vietnam. In […]

Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg, 10 mg

Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg, the generic version of Evekeo 1 Tablets, 5 mg and 10 mg, of Arbor Pharmaceuticals, LLC. According to IQVIATM sales data for the 12 month period ending November 2020, the […]